Erectile Dysfunction Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Erectile Dysfunction stocks.

Erectile Dysfunction Stocks Recent News

Date Stock Title
Oct 2 LLY Jim Cramer Remains Steadfast On Eli Lilly and Company (NYSE:LLY)
Oct 2 LLY Eli Lilly to Invest $4.5 Billion to Open New Drug Manufacturing, Development Center
Oct 2 LLY Drugmaker Lilly slates another $4.5B for manufacturing and drug development improvements
Oct 2 LLY Here's Why You Should Consider Buying Jazz Pharmaceuticals' Stock
Oct 2 PFE Johnson & Johnson's Erleada Shows Improved Overall Survival In Prostate Cancer Patients Compared To Pfizer's Drug
Oct 2 LLY Eli Lilly Commits $4.5B To New Facility, Banking On Mounjaro, Zepbound's Weight Loss Success Despite Short-Term Stock Challenges
Oct 2 LLY Eli Lilly Building $4.5B Pharmaceutical Factory in Indiana
Oct 2 LLY Novo Nordisk Is Still a Buy, Analysts Say. Slowing Growth for Ozempic and Wegovy Isn’t a Problem.
Oct 2 LLY Eli Lilly Plans $4.5 Billion Research Hub
Oct 2 LLY Eli Lilly Invests $4.5B In New Medicine Foundry for Advanced Drug Manufacturing To Push US Pharma Boundaries
Oct 2 LLY Eli Lilly Invests $4.5B In New Medicine Foundry for Advanced Drug Manufacturing To Push US Pharma Boundaries
Oct 2 LLY Eli Lilly is building a $4.5 billion factory to speed up drug production
Oct 2 LLY Eli Lilly announces $4.5B production/R&D site in Indiana
Oct 2 LLY Lilly to invest $4.5B on new Indiana facility
Oct 2 LLY Lilly to invest $4.5 billion on new Indiana facility
Oct 2 LLY Lilly announces new $4.5 billion site - the Lilly Medicine Foundry - to drive innovation in drug production and make medicines for clinical trials
Oct 2 LLY Lilly plans $4.5B ‘foundry’ for advanced drug manufacturing
Oct 2 LLY Eli Lilly Nears First Trillion Pharma Title, But Investors Caution Amid Sky-High Valuation
Oct 2 PFE Zacks Investment Ideas feature highlights: Coca-Cola, Pfizer and Altria
Oct 2 PFE 3 Sensational Ultrahigh-Yield Dividend Stocks That Make for No-Brainer Buys in the 4th Quarter (and Beyond)
Erectile Dysfunction

Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
A physical cause can be identified in about 80% of cases. These include cardiovascular disease, diabetes mellitus, neurological problems such as following prostatectomy, hypogonadism, and drug side effects. Psychological impotence is where erection or penetration fails due to thoughts or feelings; this is somewhat less frequent, in the order of about 10% of cases. In psychological impotence, there is a strong response to placebo treatment.
Treatment involves addressing the underlying causes, lifestyle modifications, and addressing psychosocial issues. In many cases, a trial of pharmacological therapy with a PDE5 inhibitor, such as sildenafil, can be attempted. In some cases, treatment can involve inserting prostaglandin tablets into the urethra, injecting smooth muscle relaxants and vasodilators into the penis, a penile prosthesis, a penis pump, or vascular reconstructive surgery. It is the most common sexual problem in men.

Browse All Tags